Enoxaparin: A Viewpoint by Greg Elliott, M.D.

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.6, 2001-06, pp. : 483-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oseltamivir: A Viewpoint by D.M. Fleming

By Fleming D.M.

Drugs, Vol. 58, Iss. 5, 1999-11 ,pp. : 861-862

Adis International

Access to resources Recommend Favorite

Telmisartan: A Viewpoint by H.L. Elliott

By Elliott H.L.

Drugs, Vol. 56, Iss. 6, 1998-12 ,pp. : 1045-1046

Adis International

Access to resources Recommend Favorite

Topiramate: A Viewpoint by Nathan Watemberg, MD

By Watemberg N.

CNS Drugs, Vol. 17, Iss. 13, 2003-01 ,pp. : 993-994

Adis International

Access to resources Recommend Favorite

Zanamivir: A Viewpoint by Douglas M. Fleming

By Fleming D.M.

Drugs, Vol. 55, Iss. 5, 1998-05 ,pp. : 726-727

Adis International

Access to resources Recommend Favorite

Rifapentine: A Viewpoint by C.M. Tam

By Tan C.M.

Drugs, Vol. 56, Iss. 4, 1998-10 ,pp. : 617-617

Adis International

Access to resources Recommend Favorite